Emma Davies

Associate Director Preclinial, Healx Ltd

Emma Davies Healx

Emma Davies, PhD is the associate director of preclinical and the scientific lead of the NF1 program at Healx. She obtained her PhD in cancer genetics from Cardiff University, Wales, UK and has over ten years experience in drug discovery developing small molecule therapies for cancer and rare diseases.

Rare Research and Funding

Rare Disease researchers take part in a poster and pitch session to share their novel approaches to engaging patients in research. Then joined by a panel of research funders to explore the challenges, opportunities and novel approaches to funding this vital research.

My three wishes for the future of rare disease are: New and more translational models of rare diseases; breakthroughs on understanding disease pathology via omics technologies; and more collaboration between industry, academia, PGs and HCPs.